Market Data
Pricing
Solutions
Log In
Market Overview
Financials
Asset Management
Parent Companies
Taizhou Huaxin Pharmaceutical Investment Co Ltd
Huaxin Pharmaceutical Hong Kong Co Ltd
2023-2
Huaxin Pharmaceutical Hong Kong Co Ltd (HAXNP) 2023-2
HYC
FNCL
HAXNP 2023-2 (USD 54m)
Taizhou Huaxin Pharmaceutical Investment Co Ltd
ABC
,
CEB
,
CTC
,
CMC
,
...
APAC
Dec 29, 2023
Missing something? Tell us.